ARE Law logo

In The Press:
IP experts debate key issues in US and China webcasts

During two Managing IP-hosted webcasts last month, participants discussed the implications of the In re Bilski decision in the US and Chinese litigation tactics. Managing IP last month hosted webcasts on the US Court of Appeals’ ruling in In re Bilski and litigation tips in China. During the Bilski discussion, patent practitioners highlighted the looming […]

In The Press:
Bilski cited in BPAI rejection

The USPTO Board of Patent Appeals and Interferences last week rejected a business method patent based on the recent ruling by the Court of Appeals for the Federal Circuit in In re Bilski. The Bilski decision, published on October 30, changed the test for determining patent-eligible subject matter in the US. In Ex Parte R […]

In The Press:
What Bilski means for you

The US Court of Appeals for the Federal Circuit in late October changed the test for determining patentable subject matter in the US. IP experts from four industries explain how the decision will affect your patents. On October 30, 2008, the Federal Circuit issued its much awaited en banc decision in In re Bilski. Chief […]

In The Press:
Innovation on the auction floor

Eileen McDermott asks James Malackowski, founder and CEO of patent auction company, Ocean Tomo, how he got here, what’s in store for the future and what the new US president should do for innovation. Why has Ocean Tomo been successful? Ocean Tomo is somewhat unique in that we have brought together professionals with IP backgrounds […]

ARE Patent Law Alert: On Remand, Federal Circuit Maintains Previous Holding That Isolated DNA Is Patent-Eligible But Methods Of Comparing Or Analyzing Isolated DNA Are Patent-Ineligible

(August 16, 2012)  On August 16, 2012, the Federal Circuit released its highly anticipated decision in Ass’n for Molecular Pathology v. USPTO and Myriad Genetics, No. 2010-1406 (Fed. Cir. August 16, 2012) (“Myriad”), on remand from the U.S. Supreme Court, concerning the patent-eligibility of isolated DNA under 35 U.S.C. § 101. The patents at issue […]

ARE Patent Law Alert: USPTO Issues Final Rules For Implementing New Post-Issuance Patent Validity Proceedings Effective On September 16, 2012

(September 4, 2012)  Among the significant changes to the U.S. patent laws made by the America Invents Act are the introduction of new procedures for challenging the validity of issued patents before the U.S. Patent and Trademark Office (“USPTO”).  These new procedures are designed to permit petitioners to bring speedy challenges to patent validity in […]

Gear Up For AIA Post-Issuance Proceedings

With the one-year anniversary of the passage of the Leahy-Smith America Invents Act comes the implementation of new post-issuance validity proceedings before the USPTO – here’s how to prepare… Click here to read the article. – Managing Intellectual Property, September 5, 2012